These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8722330)

  • 1. Safety of AlloPBPCT donors: biometrical considerations on monitoring long term risks.
    Hasenclever D; Sextro M
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S28-30. PubMed ID: 8722330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood stem cell procurement: donor safety issues.
    Anderlini P; Przepiorka D; Körbling M; Champlin R
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S35-9. PubMed ID: 9712491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
    Tigue CC; McKoy JM; Evens AM; Trifilio SM; Tallman MS; Bennett CL
    Bone Marrow Transplant; 2007 Aug; 40(3):185-92. PubMed ID: 17563736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.
    Pulsipher MA; Nagler A; Iannone R; Nelson RM
    Pediatr Blood Cancer; 2006 Apr; 46(4):422-33. PubMed ID: 16411207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
    Arimura K; Inoue H; Kukita T; Matsushita K; Akimot M; Kawamata N; Yamaguchi A; Kawada H; Ozak A; Arima N; Te C
    Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
    de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
    Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study.
    Scott MA; Gandhi MK; Jestice HK; Mahendra P; Bass G; Marcus RE
    Bone Marrow Transplant; 1998 Aug; 22(3):273-6. PubMed ID: 9720741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient respiratory disturbance by granulocyte-colony-stimulating factor administration in healthy donors of allogeneic peripheral blood progenitor cell transplantation.
    Yoshida I; Matsuo K; Teshima T; Hashimoto D; Tanimoto Y; Harada M; Tanimoto M
    Transfusion; 2006 Feb; 46(2):186-92. PubMed ID: 16441593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of cytokine-stimulated healthy donors in allogeneic stem cell transplantation.
    Cesaro S; Marson P; Gazzola MV; De Silvestro G; Destro R; Pillon M; Calore E; Messina C; Zanesco L
    Haematologica; 2002 Aug; 87(8 Suppl):35-41. PubMed ID: 12412388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study.
    Tassi C; Tazzari PL; Bonifazi F; Giudice V; Nannetti A; Ricci F; Rizzi S; Bandini G; Conte R
    Bone Marrow Transplant; 2005 Aug; 36(4):289-94. PubMed ID: 15968277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO).
    Majolino I; Cavallaro AM; Bacigalupo A; Rambaldi A; Falda M; Locatelli F; Raimondi R; Pucci G; Mordini N; Barbui T; Locatelli F; Rodeghiero F; Irrera G; Indovina A; Valbonesi M; Bellavita P; Tassi V; Perotti C; Soli M; Bresolin G
    Haematologica; 1997; 82(1):47-52. PubMed ID: 9107082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience.
    Martino M; Console G; Dattola A; Callea I; Messina G; Moscato T; Massara E; Irrera G; Fedele R; Gervasi A; Bresolin G; Iacopino P
    Bone Marrow Transplant; 2009 Aug; 44(3):163-8. PubMed ID: 19182833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term engraftment, graft-vs.-host disease, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors.
    Pan L; Bressler S; Cooke KR; Krenger W; Karandikar M; Ferrara JL
    Biol Blood Marrow Transplant; 1996 Oct; 2(3):126-33. PubMed ID: 9199755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.
    Hill GR; Morris ES; Fuery M; Hutchins C; Butler J; Grigg A; Roberts A; Bradstock K; Szer J; Kennedy G; Morton J; Durrant S
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):603-7. PubMed ID: 16737933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Collection of peripheral hematopoietic stem cells for transplantation from volunteer donors--siblings of the patients].
    Mayer J; Korístek Z; Krahulová M; Pospísil Z; Doubek M; Klabusay M; Brychtová Y; Hoffová V; Cernanská J; Krejcí M; Vorlícek J
    Vnitr Lek; 2001 Sep; 47 Suppl 1():15-28. PubMed ID: 11693058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony stimulating factor does not induce long-term DNA instability in healthy peripheral blood stem cell donors.
    Shapira MY; Kaspler P; Samuel S; Shoshan S; Or R
    Am J Hematol; 2003 May; 73(1):33-6. PubMed ID: 12701117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.